ZVRA
ZEVRA THERAPEUTICS, INC.
Key Financials
Revenue
$0
NaN%
Operating Income
$-62943000
↑ 27.7%
EPS (Diluted)
$1.35
↑ 159.2%
Total Assets
$284.7M
↑ 59.8%
Shareholders' Equity
$154.7M
↑ 289.9%
Net Income
$83.2M
↑ 178.9%
Total Liabilities
$130.1M
↓ 6.1%
Cash & Equivalents
$62.4M
↑ 84.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/17/2026 | View on SEC |
| 144 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 4 | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G | 7/31/2026 | View on SEC |
| 144 | 7/8/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZVRA |
| Company Name | ZEVRA THERAPEUTICS, INC. |
| CIK | 1434647 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (888) 958-1253 |